The importance of timing in postcardiotomy venoarterial extracorporeal membrane oxygenation: A descriptive multicenter observational study.

acute heart failure cardiac surgery extracorporeal life support extracorporeal membrane oxygenation mechanical circulatory support postcardiotomy cardiogenic shock

Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
12 2023
Historique:
received: 05 02 2023
revised: 05 04 2023
accepted: 22 04 2023
medline: 14 11 2023
pubmed: 19 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

Postcardiotomy extracorporeal membrane oxygenation (ECMO) can be initiated intraoperatively or postoperatively based on indications, settings, patient profile, and conditions. The topic of implantation timing only recently gained attention from the clinical community. We compare patient characteristics as well as in-hospital and long-term survival between intraoperative and postoperative ECMO. The retrospective, multicenter, observational Postcardiotomy Extracorporeal Life Support (PELS-1) study includes adults who required ECMO due to postcardiotomy shock between 2000 and 2020. We compared patients who received ECMO in the operating theater (intraoperative) with those in the intensive care unit (postoperative) on in-hospital and postdischarge outcomes. We studied 2003 patients (women: 41.1%; median age: 65 years; interquartile range [IQR], 55.0-72.0). Intraoperative ECMO patients (n = 1287) compared with postoperative ECMO patients (n = 716) had worse preoperative risk profiles. Cardiogenic shock (45.3%), right ventricular failure (15.9%), and cardiac arrest (14.3%) were the main indications for postoperative ECMO initiation, with cannulation occurring after (median) 1 day (IQR, 1-3 days). Compared with intraoperative application, patients who received postoperative ECMO showed more complications, cardiac reoperations (intraoperative: 19.7%; postoperative: 24.8%, P = .011), percutaneous coronary interventions (intraoperative: 1.8%; postoperative: 3.6%, P = .026), and had greater in-hospital mortality (intraoperative: 57.5%; postoperative: 64.5%, P = .002). Among hospital survivors, ECMO duration was shorter after intraoperative ECMO (median, 104; IQR, 67.8-164.2 hours) compared with postoperative ECMO (median, 139.7; IQR, 95.8-192 hours, P < .001), whereas postdischarge long-term survival was similar between the 2 groups (P = .86). Intraoperative and postoperative ECMO implantations are associated with different patient characteristics and outcomes, with greater complications and in-hospital mortality after postoperative ECMO. Strategies to identify the optimal location and timing of postcardiotomy ECMO in relation to specific patient characteristics are warranted to optimize in-hospital outcomes.

Identifiants

pubmed: 37201778
pii: S0022-5223(23)00366-5
doi: 10.1016/j.jtcvs.2023.04.042
pii:
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1670-1682.e33

Investigateurs

Justine Ravaux (J)
Ann-Kristin Schaefer (AK)
Luca Conci (L)
Philipp Szalkiewicz (P)
Jawad Khalil (J)
Sven Lehmann (S)
Jean-Francois Obadia (JF)
Nikolaos Kalampokas (N)
Erwan Flecher (E)
Dinis Dos Reis Miranda (DDR)
Kogulan Sriranjan (K)
Michael A Mazzeffi (MA)
Nazli Vedadi (N)
Marco Di Eusanio (M)
Graeme MacLaren (G)
Vitaly Sorokin (V)
Alessandro Costetti (A)
Chistof Schmid (C)
Roberto Castillo (R)
Vladimir Mikulenka (V)
Marco Solinas (M)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Silvia Mariani (S)

Cardio-Thoracic Surgery Department, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CAIRM), Maastricht, The Netherlands. Electronic address: s.mariani1985@gmail.com.

I-Wen Wang (IW)

Division of Cardiac Surgery, Memorial Healthcare System, Hollywood, Calif.

Bas C T van Bussel (BCT)

Department of Intensive Care Medicine, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.

Samuel Heuts (S)

Cardio-Thoracic Surgery Department, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CAIRM), Maastricht, The Netherlands.

Dominik Wiedemann (D)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Diyar Saeed (D)

Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.

Iwan C C van der Horst (ICC)

Department of Intensive Care Medicine, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.

Matteo Pozzi (M)

Department of Cardiac Surgery, Louis Pradel Cardiologic Hospital, Lyon, France.

Antonio Loforte (A)

Division of Cardiac Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Udo Boeken (U)

Department of Cardiac Surgery, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.

Robertas Samalavicius (R)

II Department of Anesthesiology, Centre of Anesthesia, Intensive Care and Pain management, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.

Karl Bounader (K)

Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France.

Xiaotong Hou (X)

Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessels Diseases, Beijing Anzhen Hospital, Beijing, China.

Jeroen J H Bunge (JJH)

Department of Intensive Care Adults, Erasmus MC, Rotterdam, The Netherlands.

Hergen Buscher (H)

Department of Intensive Care Medicine, Center of Applied Medical Research, St Vincent's Hospital, Darlinghurst, Australia.

Leonardo Salazar (L)

Department of Cardiology, Fundación Cardiovascular de Colombia, Bucaramanga, Colombia.

Bart Meyns (B)

Department of Cardiac Surgery, University Hospitals Leuven, and Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.

Daniel Herr (D)

Departments of Medicine and Surgery, University of Maryland, Baltimore, Md.

Sacha Matteucci (S)

SOD Cardiochirurgia Ospedali Riuniti 'Umberto I-Lancisi-Salesi' Università Politecnica delle Marche, Ancona, Italy.

Sandro Sponga (S)

Division of Cardiac Surgery, Cardiothoracic Department, University Hospital of Udine, Udine, Italy.

Kollengode Ramanathan (K)

Cardiothoracic Intensive Care Unit, National University Heart Centre, National University Hospital, Singapore, Singapore.

Claudio Russo (C)

Cardiac Surgery Unit, Cardiac Thoracic and Vascular Department, Niguarda Hospital, Milan, Italy.

Francesco Formica (F)

Department of Medicine and Surgery, Cardiac Surgery Clinic, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy, and Department of Medicine and Surgery, University of Parma, Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy.

Pranya Sakiyalak (P)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand.

Antonio Fiore (A)

Department of Cardio-Thoracic Surgery, University Hospital Henri-Mondor, Créteil, Paris, France.

Daniele Camboni (D)

Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.

Giuseppe Maria Raffa (GM)

Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy.

Rodrigo Diaz (R)

ECMO Unit, Departamento de Anestesia, Clínica Las Condes, Santiago, Chile.

Jae-Seung Jung (JS)

Department of Thoracic and Cardiovascular Surgery, Korea University Anam Hospital, Seoul, South Korea.

Jan Belohlavek (J)

2nd Department of Internal Medicine, Cardiovascular Medicine General Teaching Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.

Vin Pellegrino (V)

Intensive Care Unit, The Alfred Hospital, Melbourne, Australia.

Giacomo Bianchi (G)

Ospedale del Cuore Fondazione Toscana "G. Monasterio", Massa, Italy.

Matteo Pettinari (M)

Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.

Alessandro Barbone (A)

Cardiac Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

José P Garcia (JP)

IU Health Advanced Heart & Lung Care, Indiana University Methodist Hospital, Indianapolis, Ind.

Kiran Shekar (K)

Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, Australia.

Glenn Whitman (G)

Cardiac Intensive Care Unit, Johns Hopkins Hospital, Baltimore, Md.

Roberto Lorusso (R)

Cardio-Thoracic Surgery Department, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CAIRM), Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH